The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pathologic response rates from neoadjuvant chemotherapy in muscle-invasive transitional cell carcinoma of the bladder.
W. P. Harris
No relevant relationships to disclose
E. Y. Yu
No relevant relationships to disclose
J. Shenoi
No relevant relationships to disclose
F. Lee
No relevant relationships to disclose
T. Champion
No relevant relationships to disclose
J. L. Wright
No relevant relationships to disclose